Conversely, decreased AR expression and AR-responsive gene signaling is often observed in PTEN-deficient prostate cancer cells and, in this setting, inhibition of PI3K/AKT signaling results in the reactivation of AR through a reciprocal feedback loop between AR and AKT [13,14,15]. Here, PTEN is linked to prostate cancer.